藍豐生化(002513.SZ)大幅下修業績 2019年預虧2.8億元-3.8億元
格隆匯1月22日丨藍豐生化(002513.SZ)披露2019年度業績預告修正公告,修正前,公司預計2019年度歸屬於上市公司股東的淨利潤為盈利2800萬元-3800萬元;修正後,公司預計2019年度歸屬於上市公司股東的淨利潤為虧損2.8億元-3.8億元,而上年同期為虧損8.75億元。業績修正原因説明:
1、公司全資子公司陝西方舟製藥有限公司受宏觀經濟和深化醫藥改革影響,在藥審改革、一致性評價、“4+7”帶量採購、新醫保目錄、處方外流等多項政策影響下,經營業績不達預期。公司在年度終了對方舟製藥所涉商譽進行了初步減值測試,根據初步減值測試結果,商譽存在減值跡象,基於謹慎原則,計提商譽減值準備。
2、受江蘇省安全環保整治行動及市場原因的影響,公司農化業務部分裝置開車不足,產能利用率下降,公司根據會計準則的規定,對部分固定資產計提資產減值損失。
3、公司前次業績預計時,未對商譽進行減值測試,未考慮商譽及其他大額資產減值損失對業績的影響。
4、公司計劃聘請專業評估機構對相關資產可收回金額進行評估,以確定具體資產減值金額,最終計提資產減值對公司業績的影響尚存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.